View Article

Abstract

Diuretics are medicines that make the body pass more urine and salt. They work by blocking sodium (salt) reabsorption in different parts of the kidney: ? Proximal tubule ? SGLT2 inhibitors, carbonic anhydrase inhibitors. ? Loop of Henle ? loop diuretics. ? Distal tubule ? thiazide and thiazide-like diuretics. ? Collecting tubule ? mineralocorticoid receptor antagonists. Because each type works in a different way, they can be combined for better effect. These drugs are used to treat problems like heart failure, kidney diseases, and high blood pressure. ? SGLT2 inhibitors lower blood pressure, protect the heart and kidneys, and don?t disturb sodium or potassium levels. ? Acetazolamide helps in acute heart failure. ? Loop diuretics reduce high blood pressure and extra fluid in the body, but sometimes cause electrolyte imbalance. ? Thiazide diuretics mainly lower blood pressure, but can cause low sodium (hyponatremia) and low potassium (hypokalaemia). ? Mineralocorticoid receptor antagonists also protect the heart and kidneys and reduce blood pressure, but may cause high potassium (hyperkalaemia).

Keywords

Diuretics, Classification of diuretics, SGLT2 Inhibitors, Carbonic anhydrase inhibitors, Loop diuretics, Thiazide diuretics. Mineralocorticoid receptor antagonist, Types, Mechanism of action

Introduction

× Popup Image

This article explains the main types of diuretics (water pills) and how they are used to treat kidney problems and high blood pressure. Diuretics are medicines that help the body get rid of extra water and salt by making you urinate more. Different types of diuretics work in

different ways, so doctors can combine them for better results. These medicines act on different parts of the kidney’s filtering system — the proximal tubule, loop of Henle, distal tubule, and collecting tubule [1].

Reference

  1. Filippatos TD, Tsimihodimos V, Elisaf MS. How SGLT2 inhibitors lower blood pressure. Expert Opin Pharmacother. 2016;17(12):1581–1583. Shows how SGLT2 inhibitors help reduce blood pressure.
  2. Scheen AJ. Lowering blood pressure in people with type 2 diabetes using SGLT2 inhibitors. Diabetes Res Clin Pract. 2016; 121:204–214.
  3. Bjornstad P, et al. How SGLT2 inhibitors affect sodium in the body and heart failure. J Card Fail. 2021;27(12):1447–1455.
  4. Dekkers CCJ, et al. SGLT2 inhibitors and diabetic kidney disease. Curr Diab Rep. 2018;18(5):27.
  5. Kawasoe S, et al. How SGLT2 inhibitors lower blood pressure in obese people with type 2 diabetes. BMC Pharmacol Toxicol. 2017; 18:23.
  6. Fukuoka S, et al. Diuretic effects of SGLT2 inhibitors in diabetes and heart failure. Int J Cardiol. 2015; 201:1–3.
  7. Griffin M, et al. Empagliflozin’s effects on heart and kidneys. Circulation. 2020;142(11):1028–1039.
  8. Szekeres Z, et al. Effects of SGLT2 inhibitors on fat and cholesterol. Metabolites. 2021;11(2).
  9. Ohara K, et al. How dapagliflozin changes body fluid compared to furosemide and tolvaptan. Nephrology (Carlton). 2019;24(9):904–911.
  10. Karg MV, et al. Dapagliflozin reduces sodium in tissues. Cardiovasc Diabetol. 2018; 17:5.
  11. Noble MIM, et al. Damage to the protective layer in arteries may start heart disease. QJM. 2008;101(7):513–518.
  12. Fels J, et al. Tiny mechanical properties of blood vessel lining. Cell Tissue Res. 2014;355(3):727–737.
  13. Oberleithner H, et al. Too much salt harms the artery lining. Pflugers Arch. 2011;462(4):519–528.
  14. Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007; 356:2064–2072.doi:10.1056/NEJMra067110.
  15. Ellison DH. Diuretic Therapy and Resistance in Patients with Heart Failure. N Engl J Med. 2019; 380:539–548.doi:10.1056/NEJMra1806010.
  16. Rangaswami J, McCullough PA, et al. Diuretics in hea. rt failure and chronic kidney disease: a review. Kidney Int. 2018;93(3): 635–647. doi: 10.1016/j.kint.2017.11.023.

Photo
Akash Jadhav
Corresponding author

Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad -415509

Photo
Aishwarya Pise
Co-author

Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad -415509

Photo
Varad Dhobale
Co-author

Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad -415509

Akash Jadhav*, Varad Dhobale, Aishwarya Pise, Diuretics ? A Review of the Current Knowledge, Int. J. Sci. R. Tech., 2025, 2 (11), 432-437. https://doi.org/10.5281/zenodo.17627361

More related articles
“A Study to Assess the Effectiveness of a Struct...
Srishti, Surbhi, Sonu Sagar, Shivani Yadav, Mahima Singh, Anju Si...
Knowledge of Open Suctioning Techniques Among Inte...
Eshika Santhosh, Ringkangmai Liangkiuwiliu, Jamiya Khatun...
A Descriptive Study to Assess the Knowledge of Mother Regarding Developmental Mi...
Ajay Kawar, Shantanu Kamble, Sarika Satpute, Rupali Watharkar, Ashwini Patil...
Knowledge and Attitude Regarding Human Milk Banking Among Antenatal Mothers in S...
Manphun Wangsu, Nongmeikapam Monika, Iarihunlang Lyngdoh...
Related Articles
“A Quasi Experimental Study to Evaluate the Effectiveness of Planned Teaching ...
Mohd. Salim, Mrs. Karishma Goswami, Mrs. Akanksha Emmanuel, Mohd. Soyeb, Mohd. Aakil, Mohammad Arzoo...
“Effectiveness of an Educational Interventional Programme on Knowledge Regardi...
Aman Patel, Dinesh Singh, Ankit Singh, Anjali Pal, Anitha P., Anamika Bharti...
“A Study to Assess the Effectiveness of a Structured Teaching Programme on Kno...
Sanjay Kumar, Sikha Singh, Shivam, Satyaprakash, Saloni Bharti, Anurag Sharma...
A Study to Assess the Effectiveness of Structured Teaching Programme on Knowledg...
Pooja Mandal, Shweta Singh, Priyanka Gautam, Om Srivastava, Nitish Chourasiya, Deepak Kumar Sampson...
“A Study to Assess the Effectiveness of a Structured Teaching Programme on Kno...
Srishti, Surbhi, Sonu Sagar, Shivani Yadav, Mahima Singh, Anju Singh...